Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Mold Intervention in Public Housing Reduces Asthma-Related Emergency Department Visits
This is a paid press release. Contact the press release distributor directly with any inquiries.
Mold Intervention in Public Housing Reduces Asthma-Related Emergency Department Visits
PR Newswire
Wed, February 18, 2026 at 10:00 PM GMT+9 2 min read
Mold reduction resulted in 2,798 fewer emergency department visits per year
MILWAUKEE, Feb. 18, 2026 /PRNewswire/ – City-wide Mold Busters initiative from the New York City Housing Authority (NYCHA) reduced asthma-related emergency department (ED) visits for public housing residents, according to new research being presented at the 2026 AAAAI Annual Meeting.
“Our study demonstrates that the system-wide mold intervention, Mold Busters, is making a difference for NYC public housing residents by successfully intervening on mold that triggers severe asthma attacks necessitating a visit to the emergency department,” says lead author Nina Flores, PhD, a postdoctoral fellow at the University of Texas Austin and recent graduate from Columbia University’s Environmental Health Sciences department. “Beyond the health-related benefits we capture with emergency department visit data, it is likely that Mold Busters is delivering other benefits to NYC public housing residents, including the prevention of new asthma cases, as well as the prevention of less severe asthma symptoms and other allergic reactions that may necessitate school and work absences and unscheduled medical appointments outside of the emergency department.”
This study highlights the impact of city-wide public housing mold intervention as a public health initiative; however, researchers make note that the impact of extreme precipitation suggests that additional targeted, climate-focused interventions may be necessary.
In the study, researchers examined data on asthma-related ED visits among NYCHA residents from 2016 to 2023 and compared it to data obtained from a Mold Busters unexposed group living in proximate, non-NYCHA lower-income census tracts. To assess the impact of Mold Busters, a program from the NYCHA to remediate mold, researchers used doubly robust differences-in-differences analyses and resident-reported building-level data to evaluate changes in mold work orders after Mold Busters intervention, while considering extreme precipitation events and building and neighborhood characteristics.
The Mold Busters intervention was associated with an average annual reduction of nine asthma-related ED visits per 1,000 residents, translating to an average of 2,798 fewer ED visits per year. The effects were stronger for adults and those in buildings that experienced larger decreases in mold reports.
Visit aaaai.org to learn more about mold allergies. Research presented at the 2026 AAAAI Annual Meeting, February 27 – March 2 in Philadelphi, PA, is published in an online supplement to _The Journal of Allergy and Clinical Immunology _(JACI).
The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists and other professionals with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders.
Media Contact
Candace Archie, The American Academy of Allergy, Asthma & Immunology, (414) 272-6071, carchie@aaaai.org, aaaai.org
Cision
View original content to download multimedia:
Terms and Privacy Policy
Privacy Dashboard
More Info